Commission on the Regulation of U.S. Capital Markets
1min
Assisted the Commission on the Regulation of U.S. Capital Markets in the 21st Century by advising on retirement plan issues and drafting related recommendations for report published March 2007.
Related Insights
Amgen Files Three New Prolia® / Xgeva® BPCIA Litigations Against Hikma, Shanghai Henlius Biotech, and Biocon’s Proposed Biosimilars